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  25 
ABSTRACT 26 
A reduction in central blood volume can lead to cardiovascular decompensation (i.e., 27 
failure to maintain blood pressure). Cooling the forehead and cheeks using ice water 28 
raises blood pressure. Therefore, face cooling (FC) could be used to mitigate decreases 29 
in blood pressure during central hypovolemia. Purpose We tested the hypothesis that 30 
FC during central hypovolemia induced by lower body negative pressure (LBNP) would 31 
increase blood pressure. Methods Ten healthy participants (222 years, 3 women) 32 
completed two randomized LBNP trials on separate days. Trials began with 30 mmHg 33 
of LBNP for 6 minutes. Then, a 2.5 L plastic bag of ice water (00C) (LBNP+FC) or 34 
thermoneutral water (341C) (LBNP+Sham) was placed on the forehead, eyes, and 35 
cheeks during 15 minutes of LBNP at 30 mmHg. Results Forehead temperature was 36 
lower during LBNP+FC vs. LBNP+Sham with the greatest difference at 21 minutes of 37 
LBNP (11.11.6 vs. 33.91.4C, P < 0.001). Mean arterial pressure was greater during 38 
LBNP+FC vs. LBNP+Sham with the greatest difference at 8 minutes of LBNP (9815 39 
vs. 808 mmHg, P < 0.001). Cardiac output was higher during LBNP+FC vs. 40 
LBNP+Sham with the greatest difference at 18 minutes of LBNP (5.91.4 vs. 4.91.0 41 
L/min, P = 0.005). Forearm cutaneous vascular resistance was greater during 42 
LBNP+FC vs. LBNP+Sham with the greatest difference at 15 minutes of LBNP (7.23.4 43 
vs. 4.92.7 mmHg/PU, P < 0.001). Conclusion Face cooling during LBNP increases 44 
blood pressure through increases in cardiac output and vascular resistance.  45 
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 48 
INTRODUCTION 49 
Blood loss and other clinical situations (i.e., postural orthostatic tolerance, sepsis, 50 
Dengue fever, etc.) can cause central hypovolemia and lead to cardiovascular 51 
decompensation (i.e., inability to maintain blood pressure). Several methods aimed at 52 
maintaining blood pressure during central hypovolemia have been investigated in the 53 
prehospital setting or in the laboratory. Intravenous saline infusions are common in the 54 
prehospital setting to counteract central hypovolemia. However, intravenous saline 55 
infusions increase the risk of coagulopathy (38) and necessary blood transfusions (18) 56 
in trauma patients. Furthermore, this method requires venous access, which can be 57 
difficult to obtain during central hypovolemia (13). Respiratory impedance devices 58 
improve blood pressure in a variety of models of central hypovolemia (i.e., large 59 
animals, healthy volunteers, and patients) (9-11, 25, 27, 35, 36). However, the patient 60 
must have an adequate ventilatory drive for the device to be effective. In this regard, 61 
whole-body surface skin cooling has also been used to increase blood pressure during 62 
central hypovolemia in humans (12, 14, 30). However, whole-body surface skin cooling 63 
is impractical for prehospital use due to its size and the need for a power source to chill 64 
and circulate the coolant. Therefore, a practical, prehospital technique is needed to 65 
prevent or delay cardiovascular decompensation when patients experience central 66 
hypovolemia.  67 
Cooling the forehead and cheeks stimulates the trigeminal nerve which elicits an 68 
increase in cardiac parasympathetic activity followed by a rise in sympathetic activity 69 
(17). Despite the transient increase in cardiac parasympathetic activity, face cooling 70 
causes substantial increases in blood pressure that can be maintained for 15 minutes or 71 
more (37). Therefore, simply cooling the forehead and cheeks might be an effective 72 
intervention to maintain or improve blood pressure in individuals during acute periods of 73 
central hypovolemia. Two minutes of face cooling during central hypovolemia induced 74 
by lower body negative pressure (LBNP) prevents a decrease in mean arterial pressure 75 
(8). Therefore, the purpose of our study was to test the hypothesis that cooling the 76 
forehead, eyes, and cheeks would raise blood pressure for up to 15 minutes during 77 
central hypovolemia in healthy humans.  78 
METHODS 79 
Participants 80 
 Ten healthy participants (age: 22  2 years; 3 women; height: 174  10 cm; 81 
weight: 73  13 kg) completed the study. Participants self-reported to be free from 82 
autonomic, cardiovascular, respiratory, metabolic, or endocrine diseases. All 83 
participants self-reported to be non-smokers and were not taking any medications 84 
(except oral contraceptives; n = 1). Women were not pregnant (confirmed by a negative 85 
urine pregnancy test) and we did not control for menstrual cycle hormones. All 86 
participants were fully informed of the experimental procedures and possible risks 87 
before giving informed, written consent. The study was approved by the Institutional 88 
Review Board at the University at Buffalo and was performed in accordance with the 89 
standards set by the latest revision of the Declaration of Helsinki. 90 
 91 
Experimental Approach 92 
 Participants completed two randomized study visits: one LBNP with face cooling 93 
(LBNP+FC) and one LBNP with sham (LBNP+Sham). For both study visits, we asked 94 
participants to report to the temperature controlled (23  1 C, 21  6% relative 95 
humidity) laboratory after abstaining from exercise, alcohol, and caffeine for at least 12 96 
hours and food for at least 2 hours. After participants were instrumented, we secured 97 
them to the LBNP chamber in the supine position using a neoprene kayak skirt that was 98 
sealed at the level of the iliac crest. After a 10-minute rest period, we collected baseline 99 
data for an additional 10 minutes. At the end of baseline, 30 mmHg of LBNP 100 
commenced for 6 minutes. This represents a moderate level of LBNP that elicits central 101 
hypovolemia (e.g., ~6.8 mmHg reduction in central venous pressure) and hemodynamic 102 
responses that are associated with upwards of 1,000 mL of blood loss in humans (21). 103 
Then, we placed a pliable plastic bag filled with ice water (LBNP+FC) or thermoneutral 104 
water (LBNP+Sham) on the forehead, eyes, and cheeks for the next 15 minutes while 105 
30 mmHg of LBNP was maintained. The volume of water in the plastic bag was 2.5 106 
liters in both trials and the bags were agitated every 3 minutes. After 15 minutes of face 107 
cooling or sham, LBNP was terminated, the plastic bag was removed, and water 108 
temperature was measured using a thermocouple (Omega Engineering, Stanford, CT; 109 
face cooling: 0  0C; sham: 34  1C). After the termination of face cooling or sham, 110 
participants remained supine and we collected 5 minutes of recovery data. 111 
 112 
Instrumentation and Measurements 113 
 Height and weight were measured using a stadiometer and scale (Sartorius, 114 
Bohemia, NY) prior to the study visits. A 3-lead electrocardiogram (DA100C, Biopac 115 
Systems, Goleta, CA) was used to continuously record heart rate and the Penaz 116 
method was used to collect beat-to-beat blood pressure (Finometer Pro; FMS, 117 
Amsterdam, The Netherlands). Beat-to-beat blood pressure was intermittently 118 
confirmed using auscultation of the brachial artery via electrosphygmomanometry 119 
(Tango M2; SunTech, Raleigh, NC) and no corrections were needed. Stroke volume 120 
was calculated via Modelflow using the blood pressure waveform (46). Laser Doppler 121 
flowmetry (Periflux System 5010; Perimed, Stockholm, Sweden) was used to measure 122 
skin blood flow on the dorsal side of the left forearm and the pad of the left-hand index 123 
finger. Skin blood flow was measured on the fingertip to provide an index of reflex 124 
cutaneous vasoconstriction because only cutaneous vasoconstrictor nerves innervate 125 
glabrous skin (22). Both laser Doppler probes were inserted into thin plastic holders that 126 
were adhered to the skin using porous tape. Participants were also instructed to keep 127 
their left arm and hand still throughout the protocol. Forearm blood flow was measured 128 
in the right arm using venous occlusion plethysmography (48) at 10 minutes of baseline, 129 
and every 3 minutes during LBNP. A strain gauge was placed around the largest 130 
circumference of the forearm and pressure cuffs were secured around the upper arm 131 
proximal to the elbow and around the wrist. The wrist cuff was inflated to 250 mmHg 132 
and the upper arm cuff cycled between 0 mmHg and 50 mmHg every 8 seconds during 133 
each measurement period. Forearm blood flow was calculated for each cycle using the 134 
slope of the increase in forearm circumference determined by the strain gauge and the 135 
average of six cycles at each measurement period was used for statistical analyses 136 
(49). A thermocouple (Omega Engineering, Stanford, CT) was adhered to the forehead 137 
using permeable tape (Transpore, 3M, St. Paul, MN) to continuously measure forehead 138 
skin temperature. 139 
 140 
Data Analyses 141 
 We recorded data continuously at 1kHz using a data acquisition system (Biopac 142 
MP150, Goleta, CA). Data were analyzed in 1 minute segments at 10 minutes of 143 
baseline, at 3 and 6 minutes of LBNP, during each of the first 3 minutes of face cooling 144 
or sham, and every 3 minutes thereafter. Recovery data were analyzed in 1 minute 145 
segments at the end of the 5-minute recovery period (Post). We calculated the R-R 146 
intervals from the electrocardiogram during each data analysis time point. All R-waves 147 
were visually inspected for ectopic beats and manually edited where needed (37). 148 
These analyses were used to estimate changes in short-term cardiac parasympathetic 149 
activity using the root mean square of successive differences in R-R intervals (RMSSD) 150 
using WinCPRS software (Absolute Aliens, Turku, Finland) (17, 34, 37). Cardiac output 151 
was calculated as the product of heart rate and stroke volume and total peripheral 152 
resistance was calculated as the quotient of mean arterial pressure and cardiac output. 153 
Cutaneous, fingertip, and forearm vascular resistances were calculated as the quotient 154 
of mean arterial pressure and skin and forearm blood flow, respectively. 155 
 156 
Statistical Analyses 157 
 Two-way repeated measures ANOVA were used to compare responses between 158 
LBNP+FC and LBNP+Sham (condition effect) and within experimental conditions (time 159 
effect). We used the Holm-Sidak post hoc procedure to determine where differences 160 
existed if the ANOVA revealed a significant interaction or main effect. Data over time 161 
were compared to those acquired at the 10-minute baseline. All data were assessed for 162 
approximation to a normal distribution and sphericity and no corrections were made. 163 
Statistical analyses were performed using Prism software (Version 6, GraphPad 164 
Software, La Jolla, CA). Data are reported as means  SD and P values are reported. 165 
 166 
RESULTS 167 
Forehead skin temperature There were no differences between conditions in 168 
forehead skin temperature at baseline or during the first 6 minutes of LBNP (Figure 1). 169 
Forehead skin temperature was lower than baseline and LBNP+Sham throughout the 170 
entire face cooling procedure and 5 minutes after the cooling stimulus had been 171 
removed (P < 0.001).  172 
Blood pressure There were no differences in mean arterial pressure between 173 
conditions at baseline or during LBNP alone (P > 0.068) (Figure 2A). During LBNP 174 
alone, mean arterial pressure was not different from baseline in either condition (P > 175 
0.107). Throughout LBNP+FC, mean arterial pressure was greater than baseline (P  176 
0.001) and LBNP+Sham (P < 0.019). Mean arterial pressure remained greater than 177 
baseline 5 minutes after LBNP+FC (P < 0.001). We did not observe any change from 178 
baseline in mean arterial pressure during LBNP+Sham (P > 0.454). During LBNP alone, 179 
systolic blood pressure was lower in both conditions compared to baseline (P  0.005) 180 
(Figure 2B). Throughout LBNP+Sham, systolic blood pressure remained lower than 181 
baseline (P < 0.035). However, systolic blood pressure returned to baseline values 182 
during LBNP+FC (P  0.123). During LBNP+FC, systolic blood pressure was greater 183 
than LBNP+Sham after 2 minutes of face cooling and remained greater throughout face 184 
cooling (P < 0.002). Diastolic blood pressure was not different between conditions 185 
(condition effect: P = 0.991) nor was there an effect of time (P = 0.379) or interaction (P 186 
= 0.056) (Figure 2C).  187 
Cardiac responses The heart rate response during LBNP and LBNP+Sham was 188 
not different than baseline throughout the protocol (P > 0.211) (Figure 3A). Heart rate 189 
during LBNP alone was greater than baseline during the LBNP+FC protocol (P < 0.020) 190 
but it returned to baseline values during face cooling (P > 0.129).  There were no 191 
differences in heart rate between the conditions (P  0.186) until 2 minutes (P = 0.030), 192 
3 minutes (P = 0.014), and 6 minutes (P = 0.038) of face cooling.  193 
Stroke volume was lower in both conditions during LBNP alone when compared 194 
to baseline (P  0.001). Stroke volume remained lower than baseline throughout 195 
LBNP+Sham (P < 0.001) (Figure 3B). However, stroke volume was restored to baseline 196 
values during LBNP+FC (P > 0.108). Between conditions, stroke volume was not 197 
different during baseline, LBNP alone, or the first minute of face cooling (P > 0.121). 198 
After 2 minutes of face cooling, stroke volume was greater during LBNP+FC versus 199 
LBNP+Sham (P < 0.001). Cardiac output was lower than baseline throughout the 200 
LBNP+Sham protocol (P < 0.003) and only lower in than baseline in LBNP+FC after 2 201 
minutes of face cooling (P = 0.004) (Figure 3C). Between conditions, cardiac output was 202 
greater in LBNP+FC at several timepoints (P < 0.007). 203 
RMSSD was not different between conditions at baseline or during LBNP alone 204 
(P > 0.563) (Figure 3D). During the LBNP+Sham protocol, there were no significant 205 
changes in RMSSD from baseline (P > 0.113). During LBNP+FC, RMSSD was greater 206 
than baseline during the first 6 minutes of face cooling (P  0.035). RMSSD was also 207 
greater in LBNP+FC versus LBNP+Sham from minutes 7 to 18 (P < 0.026).  208 
Blood Flow Forearm blood flow was lower during LBNP+Sham (2.9  1.3 mL/100 209 
g tissue/ min) than LBNP+FC (5.0  2.5 mL/100 g tissue/ min) at baseline (P < 0.005); 210 
therefore, we analyzed changes from baseline forearm blood flow. The change in 211 
forearm blood flow during LBNP+Sham was lower than baseline at minute 3 only (P < 212 
0.050) (Table 1). The change in forearm blood flow during LBNP+FC was lower than 213 
baseline throughout the protocol (P < 0.002). The change in forearm blood flow was 214 
greater at minutes 15 and 21 during LBNP+FC versus LBNP+Sham (P < 0.007).  215 
Forearm cutaneous blood flow was not statistically different between conditions 216 
(P = 0.855) or throughout the protocols (P = 0.601) nor was there a significant 217 
interaction effect (P = 0.881) (Table 1).  218 
Fingertip cutaneous blood flow was greater than baseline during LBNP+Sham 219 
after 12 minutes and throughout the protocol (P < 0.005) (Table 1). Fingertip cutaneous 220 
blood flow was lower than baseline at 7 minutes of LBNP+FC (P = 0.007). Fingertip 221 
cutaneous blood flow was greater during LBNP+Sham versus LBNP+FC at minute 7 222 
and from minute 12 to the end of the protocols (P < 0.020). 223 
Vascular resistance During LBNP+Sham, total peripheral resistance was greater 224 
than baseline throughout the protocol (P < 0.041) (Figure 4A). However, during 225 
LBNP+FC, total peripheral resistance was greater than baseline starting after the first 2 226 
minutes of face cooling (P < 0.028). Total peripheral resistance was greater during 227 
LBNP+FC versus LBNP+Sham at 2 minutes of face cooling (P < 0.008). We obtained a 228 
full data set for only 7 participants for forearm vascular resistance due to technical 229 
difficulties. Forearm vascular resistance was greater during LBNP+Sham (34.7  16.3 230 
mmHg/mL/100 g tissue/min) than LBNP+FC (18.1  5.1 mmHg/mL/100 g tissue/min) at 231 
baseline (P < 0.005); therefore, we analyzed changes from baseline forearm vascular 232 
resistance. The change in forearm vascular resistance in LBNP+Sham was greater than 233 
baseline throughout the protocol (P < 0.004) (Figure 4B). In LBNP+FC, the change in 234 
forearm vascular resistance was greater than baseline only during face cooling (P < 235 
0.010). There were no differences in the change from baseline forearm vascular 236 
resistance between LBNP+Sham and LBNP+FC (P ≥ 0.060).  237 
During LBNP+Sham, forearm cutaneous vascular resistance did not change from 238 
baseline (P > 0.694) (Figure 4C). Forearm cutaneous vascular resistance was greater 239 
during LBNP+FC after 3 minutes of face cooling and throughout the protocol (P < 240 
0.021). Forearm cutaneous vascular resistance was greater than baseline at several 241 
time points in LNBP+FC (P < 0.044). During LBNP+FC, forearm cutaneous vascular 242 
resistance was greater than LBNP+Sham after 3 minutes of face cooling (P < 0.022). 243 
During LBNP+Sham, fingertip cutaneous vascular resistance was not different 244 
from baseline at any point (P > 0.915) (Figure 4D). During LBNP+FC, fingertip 245 
cutaneous vascular resistance was greater than baseline at 9 and 12 minutes of face 246 
cooling (P < 0.007). Between conditions, fingertip cutaneous vascular resistance was 247 
greater during LBNP+FC versus LBNP+Sham at minutes 7, 12, 15, 18, 21, and Post (P 248 
< 0.025). 249 
 250 
DISCUSSION 251 
 The main finding of this study is that face cooling facilitated a rapid increase in 252 
mean arterial pressure that was sustained throughout 15 minutes of 30 mmHg of LBNP. 253 
The increase in mean arterial pressure during face cooling was accomplished by a 254 
combination of increases in cardiac output and skin vascular resistance. These findings 255 
indicate that face cooling is able to augment mean arterial pressure during a central 256 
hypovolemic challenge, which suggests that this technique could be employed as a tool 257 
to prevent or delay cardiovascular decompensation during central hypovolemia. 258 
 Face cooling during two minutes of 30 mmHg of LBNP has been shown to 259 
prevent mean arterial pressure from decreasing by ~8 mmHg in healthy participants (8). 260 
However, we observed substantial increases in mean and systolic blood pressure 261 
throughout 15 minutes of LBNP+FC when compared to LBNP+Sham (Figure 2A and B). 262 
Whole-body surface skin cooling increases mean arterial pressure by ~7-8 mmHg 263 
during 30 mmHg (14, 30), 40 mmHg (12, 14), and 50 mmHg (14, 31) of LBNP. 264 
Inspiratory threshold devices increase mean arterial pressure by 22-28 mmHg during 265 
LBNP (11, 35, 36). In this context, it is thought that raising blood pressure during 266 
moderate levels of LBNP would help stabilize hemodynamics during more severe 267 
central hypovolemia and improve LBNP tolerance. However, evidence to support this 268 
idea is not entirely clear and could be dependent on the method and/or timing of 269 
increasing mean arterial pressure. For instance, the application of whole-body surface 270 
skin cooling prior to and during progressive LBNP improves LBNP tolerance by ~34% 271 
(14). Using an inspiratory threshold device throughout progressive LBNP also improves 272 
tolerance by 12-23% (11, 35, 36), whereas applying whole-body surface skin cooling 273 
after 10 minutes of 30 mmHg of LBNP followed by progressive LBNP with continued 274 
whole-body surface skin cooling does not improve LBNP tolerance (30). It is currently 275 
not known if the increase in blood pressure we observed during LBNP+FC or the timing 276 
of the face cooling application during progressive and more severe central hypovolemia 277 
will improve LBNP tolerance.  278 
Stimulating the trigeminal nerve using face cooling causes a transient increase in 279 
cardiac parasympathetic activity that lasts 2-3 minutes (17, 37). However, when facial 280 
cooling was applied during LBNP, the increase in cardiac parasympathetic activity 281 
above baseline values persisted for 6 minutes (Figure 3D). Moreover, cardiac 282 
parasympathetic activity during LBNP+FC was greater that LBNP+Sham for 12 minutes. 283 
The increase in cardiac parasympathetic activity decreased heart rate during face 284 
cooling (Figure 3A), which most likely allowed for an increase in end diastolic volume (1, 285 
47). We speculate that the increase in end diastolic volume during face cooling 286 
improved the Frank-Starling relationship that prevented the fall in stroke volume during 287 
LBNP+FC (Figure 3B). Although heart rate was lower during LBNP+FC versus 288 
LBNP+Sham, the augmented stroke volume during LBNP+FC prevented the fall in 289 
cardiac output that was seen during LBNP+Sham. Therefore, the greater cardiac output 290 
during LBNP+FC contributed to the increases in both systolic and mean arterial 291 
pressure.  292 
 In addition to augmenting cardiac parasympathetic activity, facial cooling also 293 
causes robust increases in sympathetic nerve activity (17, 19, 39) that translate to 294 
increased resistance in a variety of vascular beds (5, 16, 17, 20, 29). It is currently not 295 
known if sympathetic activity (i.e., muscle or skin sympathetic nerve activity) is 296 
increased beyond 3 minutes of face cooling (17, 19, 39). However, our previous study 297 
demonstrates that forearm vascular resistance can be augmented for up to 15 minutes 298 
during face cooling (37), which suggests that sympathetic activity is elevated throughout 299 
the duration of face cooling. Although we did not observe further sustained increases in 300 
total peripheral resistance and forearm vascular resistance during LBNP+FC, we did 301 
observe increases in forearm and fingertip cutaneous vascular resistance, which 302 
primarily occurred during the latter portions of LBNP+FC (minute 9 through Post, and 303 
minute 7 and minutes 12 through Post, respectively) (Figure 4C & D). These results 304 
indicate that skin sympathetic vasoconstrictor nerve activity is likely increased during 305 
LBNP+FC. Furthermore, we speculate that the increases in skin vascular resistance 306 
offset a potential reduction in vascular resistance to vital organs during LBNP+FC, 307 
which resulted in no differences in total peripheral resistance between LBNP+FC and 308 
LBNP+Sham.  However, additional work is needed to discern if increases in skin 309 
vascular resistance during LBNP+FC cause a redistribution of blood flow to mitigate 310 
decreases in central blood volume. 311 
Experimental Considerations 312 
 Our study has several limitations worth noting. First, we did not take participants 313 
to LBNP tolerance. This would have provided valuable applied information regarding the 314 
capability of face cooling to prevent or delay cardiovascular decompensation during 315 
severe central hypovolemia (i.e., blood loss). Nonetheless, we have provided evidence 316 
that face cooling during a constant moderate level of LBNP increases blood pressure. 317 
Second, we did not control for menstrual cycle hormones. Because the timing of 318 
hypotensive states (i.e., trauma-induced blood loss, sepsis, etc.) is unpredictable, we 319 
chose not to control for menstrual cycle hormones despite their influence on blood 320 
pressure regulation (28) and sympathetic responses to LBNP (7, 45). Third, we did not 321 
quantify cardiovascular fitness or exercise training status in our participants, which have 322 
been shown to influence hemodynamic responses to LBNP (24, 26, 32, 33, 42). Fourth, 323 
blood loss is commonly associated with hypothermia (6), which can lead to 324 
coagulopathy (4). However, we currently do not know if face cooling influences 325 
coagulopathy in hypothermic trauma patients. Finally, we did not clamp respiratory rate 326 
or tidal volume between conditions, which could have influenced our measure of cardiac 327 
parasympathetic activity (i.e., RMSSD) (43). Currently, the interaction between face 328 
cooling and LBNP on ventilatory pattern and stability is not known.  329 
 330 
Perspectives and Significance 331 
 Blood loss is the leading cause of civilian and battlefield trauma deaths (15). 332 
Approximately 91% of potentially survivable deaths on the battlefield are blood loss-333 
related (15, 23) and it is estimated that ~25% of these deaths could have been 334 
prevented by timely intervention and treatment. These preventable deaths underscore 335 
the need for rapid and simple prehospital interventions to maintain or restore blood 336 
pressure before and during transport or evacuation (2). This study is the first step 337 
towards the possibility of using face cooling to mitigate cardiovascular decompensation 338 
during blood loss or other conditions involving central hypovolemia. Combat medics and 339 
first responders could carry chemical ice packs in their medic bags and apply them to a 340 
patient’s forehead following blood loss. However, we believe that using forehead cooling 341 
to prevent cardiovascular decompensation is situational. For instance, if active bleeding 342 
is occurring, either internal or external, a further increase in blood pressure could 343 
augment blood loss and promote cardiovascular decompensation. Therefore, face 344 
cooling should only be used after the bleeding is controlled. Furthermore, it is common 345 
for medical personal to allow blood pressure to remain low (i.e. permissive hypotension) 346 
prior to the addition of fluid to prevent the rupture of newly formed blood clots (41).  It 347 
remains to be seen, however, if face cooling can be titrated to maintain blood pressure 348 
within acceptable values. This would require an understanding of the dose-response 349 
relationship between the magnitudes of face cooling and increases in blood pressure. 350 
Moreover, it is also unclear how additional environmental factors that are commonly 351 
encountered by military and emergency personnel, such as heat stress, cold stress, 352 
hypoxia, and prior exercise influence the pressor response to face cooling during blood 353 
loss. In this context, simultaneous stimulation of both the sympathetic and 354 
parasympathetic nervous systems (i.e. “autonomic conflict”) due to blood loss and face 355 
cooling, respectively, could contribute to an increased risk of cardiac arrhythmias in 356 
some patients (3, 40, 44). Consequently, further research is needed to determine if face 357 
cooling is feasible for the prevention of cardiovascular decompensation during blood 358 
loss, or other central hypovolemic challenges, in a variety of environmental and 359 
physiological conditions. 360 
 361 
Conclusions 362 
 We have demonstrated that face cooling during moderate LBNP increases mean 363 
arterial pressure throughout the duration of face cooling. The increase in mean arterial 364 
pressure during LBNP was accomplished by increases in both cardiac output and skin 365 
vascular resistance. Moreover, the application of face cooling during LBNP provoked 366 
temporal increases in cardiac parasympathetic activity and sympathetic activity, both of 367 
which contributed to the increase in mean arterial pressure. 368 
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 536 
  537 
Figure 1. Forehead skin temperature during both protocols. After a 10 minute baseline 538 
resting period, 30 mmHg of lower body negative pressure (LBNP) was applied for 21 539 
minutes. After 6 minutes of LBNP, a pliable plastic bag filled with either ice water (Face 540 
Cooling) or thermoneutral water (Sham) was applied over the forehead, cheeks, and 541 
eyes for 15 minutes (n = 10). Values are expressed as means  SD. B = different from 542 
baseline (P < 0.001), * = different from Sham (P < 0.001). 543 
 544 
Figure 2. Mean arterial pressure (n = 10) (A), systolic blood pressure (n = 10) (B), and 545 
diastolic blood pressure (n = 10) (C) during both protocols. Values are expressed as 546 
means  SD. B = different from baseline (P < 0.050), * = different from Sham (P < 547 
0.050). 548 
 549 
Figure 3. Heart rate (n = 10) (A), stroke volume (n = 10) (B), cardiac output (n = 10) (C), 550 
and the root mean square of successive differences of the R-R interval (RMSSD) (n = 551 
10) (D) during both protocols. Values are expressed as means  SD. B = different from 552 
baseline (P < 0.050), * = different from Sham (P < 0.050). 553 
 554 
Figure 4. Total peripheral resistance (n = 10) (A), the change from baseline in forearm 555 
vascular resistance (n = 7) (B), forearm cutaneous vascular resistance (n = 10) (C), and 556 
fingertip cutaneous vascular resistance (n = 10) (D) during both protocols. Values are 557 
expressed as means  SD. B = different from baseline (P < 0.050), * = different from 558 
Sham (P < 0.050). 559 
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